Core Insights - Analog Devices (ADI) is expected to report quarterly earnings of $1.93 per share, a 22.2% increase year-over-year, with revenues projected at $2.76 billion, reflecting a 19.2% increase compared to the same period last year [1] Revenue Estimates by End Market - Revenue from the Consumer end market is forecasted to reach $352.36 million, indicating an 11.3% increase from the prior-year quarter [4] - Revenue from the Communications end market is projected at $321.10 million, suggesting a 20.4% year-over-year change [4] - Revenue from the Automotive end market is likely to be $798.62 million, reflecting a 19.1% increase from the year-ago quarter [5] - Revenue from the Industrial end market is expected to reach $1.27 billion, indicating a 20.3% year-over-year change [5] Market Performance - Over the past month, shares of Analog Devices have returned -2%, while the Zacks S&P 500 composite has seen a +3.3% change [5] - Currently, ADI holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [5]

Core Viewpoint - Analysts expect Medtronic to report quarterly earnings of $1.23 per share, indicating no change from the previous year, with revenues projected at $8.37 billion, reflecting a 5.7% increase year-over-year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [1][2] Revenue Projections - Analysts predict 'Net Sales- World Wide Revenue- Neuroscience- Specialty Therapies' at $728.31 million, a year-over-year increase of 2.2% [4] - 'Net Sales- World Wide Revenue- Cardiovascular- Coronary & Peripheral Vascular' is expected to reach $631.16 million, reflecting a 2.5% increase [4] - 'Net Sales- World Wide Revenue- Neuroscience- Cranial & Spinal Technologies' is forecasted at $1.20 billion, indicating a 5% increase [5] - 'Net Sales- U.S. Revenue' is estimated at $4.26 billion, suggesting a 4.3% year-over-year change [6] - 'Net Sales- ROW- Cardiovascular' is projected to reach $1.71 billion, reflecting a 6.6% increase [8] Specific Segment Insights - 'Net Sales- U.S. Revenue- Neuroscience- Neuromodulation' is expected to be $332.01 million, indicating a 6.4% increase [7] - 'Net Sales- ROW- Neuroscience- Specialty Therapies' is estimated at $326.25 million, reflecting a 3.9% increase [7] - 'Net Sales- ROW- Medical Surgical- Surgical & Endoscopy' is projected at $960.12 million, indicating a 4.9% increase [8] Market Performance - Over the past month, Medtronic shares have recorded returns of 3.5%, aligning with the Zacks S&P 500 composite's performance [9]

Core Viewpoint - Analysts expect Palo Alto Networks (PANW) to report quarterly earnings of $0.88 per share, reflecting a year-over-year increase of 17.3%, with revenues projected at $2.5 billion, up 14.2% from the previous year [1] Group 1: Earnings and Revenue Estimates - The consensus EPS estimate has been revised upward by 1.2% over the past 30 days, indicating a collective reassessment by analysts [1] - Revenue from 'Product' is expected to reach $553.40 million, representing a 15.2% increase from the prior year [4] - Revenue from 'Subscription and support' is projected to be $1.95 billion, indicating a 13.9% year-over-year change [4] Group 2: Detailed Revenue Breakdown - 'Subscription and support - Support' revenue is estimated at $625.85 million, reflecting a 7.6% increase from the previous year [5] - The consensus for 'Subscription revenue' stands at $1.32 billion, showing a year-over-year change of 17% [5] Group 3: Profitability Metrics - Analysts estimate 'Remaining Performance Obligation (RPO)' to reach $15.26 billion, up from $12.70 billion in the same quarter last year [6] - 'Product gross profit Non-GAAP' is projected at $435.03 million, compared to $378.70 million in the prior year [6] - 'Subscription and support gross profit Non-GAAP' is expected to be $1.50 billion, up from $1.30 billion year-over-year [7] Group 4: GAAP Profit Estimates - 'Subscription and support gross profit GAAP' is anticipated to reach $1.43 billion, compared to $1.24 billion in the same quarter last year [7] - 'Product gross profit GAAP' is estimated at $422.66 million, up from $375.80 million in the prior year [8] Group 5: Market Performance - Palo Alto shares have decreased by 8.8% over the past month, contrasting with the S&P 500 composite's increase of 3.1% [8] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [8]

Group 1 - The upcoming report from Global-e Online Ltd. (GLBE) is expected to show quarterly earnings of $0.02 per share, reflecting a 115.4% increase year over year [1] - Analysts forecast revenues of $207.47 million for the quarter, indicating a year-over-year increase of 23.5% [1] - There has been no revision in the consensus EPS estimate for the quarter over the past 30 days, suggesting stability in analysts' projections [1] Group 2 - Analysts project 'Revenue by Category - Fulfillment services' to reach $112.79 million, representing a year-over-year change of +31.5% [4] - The estimate for 'Revenue by Category - Service fees' is expected to be $94.68 million, indicating a year-over-year change of +15.1% [4] - Gross Merchandise Value is forecasted to reach $1.40 billion, up from $1.08 billion reported in the same quarter of the previous year [5] Group 3 - Globale Online shares have increased by 5.2% in the past month, outperforming the Zacks S&P 500 composite, which moved up by 1.9% [5] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [5]

Core Insights - The upcoming earnings report for Madison Square Garden Entertainment (MSGE) is projected to show a quarterly loss of -$0.63 per share, reflecting a significant decline of 144.7% year-over-year [1] - Analysts forecast total revenues of $155.01 million, indicating a year-over-year decrease of 16.7% [1] Earnings Estimates - The consensus EPS estimate has been revised downward by 2.7% in the last 30 days, indicating a reassessment by covering analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3] Revenue Projections - Analysts expect total revenues from contracts with customers to be approximately $149.94 million, representing a year-over-year decline of 15.6% [5] - Food, beverage, and merchandise revenues are estimated to reach $25.09 million, indicating a significant year-over-year drop of 27.7% [5] - The consensus estimate for arena license fees and other leasing revenue stands at $5.04 million, reflecting a year-over-year change of -40.6% [6] Market Performance - Over the past month, MSG Entertainment shares have declined by 2.8%, contrasting with the Zacks S&P 500 composite's increase of 1.9% [6] - MSGE holds a Zacks Rank of 4 (Sell), suggesting it is likely to underperform the overall market in the near term [6]

Core Insights - Live Nation (LYV) is expected to report quarterly earnings of $1.03 per share, indicating no change from the previous year, with revenues forecasted at $6.81 billion, representing a 13% year-over-year increase [1] - The consensus EPS estimate has been revised upward by 0.4% in the past 30 days, reflecting analysts' reassessment of their initial estimates [1][2] Revenue Estimates - Analysts predict 'Revenue- Concerts' will reach $5.74 billion, a 15.2% increase year over year [4] - 'Revenue- Sponsorship & Advertising' is expected to be $344.66 million, indicating a 10.4% increase from the previous year [4] - The consensus estimate for 'Revenue- Ticketing' stands at $734.90 million, showing a slight increase of 0.6% from the prior year [4] Attendance and Ticket Sales - Estimated total attendance for concerts is projected at 43.62 million, up from 38.89 million in the same quarter last year [5] - The total fee-bearing number of tickets sold is expected to be 82.26 million, compared to 78.47 million in the previous year [5] - Estimated total events for concerts is projected at 14.36 million, slightly down from 14.68 million reported last year [6] Regional Insights - Estimated attendance in North America is expected to reach 25.08 million, up from 23.19 million year over year [6] - Estimated events in North America are projected at 9.55 million, down from 9.99 million in the same quarter last year [7] - Estimated attendance for international concerts is expected to be 18.45 million, compared to 15.71 million last year [8] Ticketing Metrics - Total non-fee-bearing number of tickets sold is projected at 77.09 million, up from 75.13 million year over year [8] - Total global number of tickets sold is expected to reach 159.55 million, compared to 153.60 million in the previous year [9] Stock Performance - Over the past month, Live Nation shares have recorded a return of -2.1%, while the Zacks S&P 500 composite has changed by +0.6% [10] - Based on its Zacks Rank 3 (Hold), Live Nation is expected to perform in line with the overall market in the upcoming period [10]

Core Insights - Dynatrace (DT) is expected to report quarterly earnings of $0.38 per share, reflecting a year-over-year increase of 15.2% [1] - Anticipated revenues are projected to be $466.07 million, showing a 16.7% increase compared to the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts have not revised their projections [2] - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3] Revenue Projections - Analysts estimate 'Revenues- Services' will reach $19.84 million, representing a year-over-year change of +12.5% [4] - 'Revenues- Subscriptions' are predicted to be $447.92 million, indicating a +17.4% change from the prior-year quarter [5] Key Metrics - 'Annual Recurring Revenue (ARR)- Total' is expected to reach $1.78 billion, up from $1.54 billion reported in the same quarter last year [5] - The 'Dollar-based Net Retention Rate' is projected at 109.9%, down from 112.0% in the same quarter of the previous year [6] - 'Gross profit- Subscriptions' is anticipated to be $390.94 million, compared to $328.00 million reported in the same quarter last year [6] Stock Performance - Dynatrace shares have decreased by -10.7% in the past month, contrasting with a +0.6% change in the Zacks S&P 500 composite [6] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6]

Core Viewpoint - Energy Transfer LP (ET) is expected to report quarterly earnings of $0.32 per share, reflecting an 8.6% decline year-over-year, while revenues are forecasted to increase by 21.9% to $25.26 billion [1]. Earnings Projections - The consensus EPS estimate has been revised down by 0.7% in the last 30 days, indicating a reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Estimates - Analysts project 'Midstream - Gathered volumes' to reach 20,763 billion British thermal units per day, up from 19,437 billion British thermal units per day in the same quarter last year [5]. - The estimate for 'Midstream - NGLs produced' is 1,098.09 thousand barrels of oil per day, compared to 955.00 thousand barrels per day in the same quarter last year [5]. - 'Midstream - Equity NGLs' is expected to reach 62.19 thousand barrels of oil per day, up from 56.00 thousand barrels per day in the same quarter last year [6]. - 'NGL and Refined Products Transportation and Services - NGL and refined products terminal volumes' are estimated at 1,445.17 thousand barrels of oil per day, down from 1,506.00 thousand barrels per day year-over-year [7]. - 'NGL and Refined Products Transportation and Services - NGL fractionation volumes' are projected at 1,109.81 thousand barrels of oil per day, slightly up from 1,093.00 thousand barrels per day in the same quarter last year [8]. - The estimate for 'NGL and Refined Products Transportation and Services - Refined products transportation volumes' is 577.72 thousand barrels of oil per day, down from 602.00 thousand barrels per day year-over-year [9]. - 'NGL and Refined Products Transportation and Services - NGL transportation volumes' are expected to reach 2,249.71 thousand barrels of oil per day, compared to 2,235.00 thousand barrels per day in the same quarter last year [10]. Adjusted EBITDA Estimates - 'Adjusted EBITDA- Intrastate transportation and storage' is projected at $319.20 million, down from $328.00 million in the same quarter last year [11]. - 'Adjusted EBITDA- Interstate transportation and storage' is expected to reach $423.80 million, up from $392.00 million year-over-year [11]. - 'Adjusted EBITDA- Crude oil transportation and services' is estimated at $764.45 million, down from $801.00 million in the same quarter last year [12]. - 'Adjusted EBITDA- NGL and refined products transportation and services' is projected at $993.70 million, down from $1.07 billion year-over-year [13]. - The estimated 'Adjusted EBITDA- Midstream' is $798.55 million, up from $693.00 million in the same quarter last year [13]. Stock Performance - Energy Transfer LP shares have decreased by 1% over the past month, while the Zacks S&P 500 composite has increased by 0.6% [13].

Core Viewpoint - Analysts expect Eli Lilly (LLY) to report quarterly earnings of $5.61 per share, reflecting a year-over-year increase of 43.1%, with revenues projected at $14.75 billion, up 30.5% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised downward by 1.5% in the past 30 days, indicating a reassessment by analysts [1][2] Key Metrics Forecast - Analysts predict 'Net Sales- Cyramza' at $246.20 million, a decrease of 1.1% year-over-year [4] - 'Net Sales- Humulin' is expected to be $206.10 million, down 7.8% year-over-year [4] - 'Net Sales- Humalog' is projected at $609.52 million, reflecting a decline of 3.5% from the previous year [4] - 'Net Sales- Forteo' is estimated at $62.76 million, down 10.2% year-over-year [5] - 'Net Sales- International-Forteo' is forecasted at $34.28 million, a decrease of 11% [5] - 'Net Sales- Cyramza (ROW)' is expected to reach $130.32 million, down 1.9% year-over-year [6] - 'Net Sales- Emgality (ROW)' is projected at $42.01 million, indicating a significant decline of 22.8% [6] - 'Net Sales- International-Alimta' is estimated at $17.05 million, down 20.3% from the previous year [6] - 'Net Sales- US-Humulin' is expected to be $154.98 million, down 8.5% year-over-year [7] - 'Net Sales- Emgality (US)' is projected at $135.67 million, reflecting a decrease of 1.4% [7] - 'Net Sales- US-Humalog' is estimated at $412.17 million, down 5.2% year-over-year [7] - 'Net Sales- US-Forteo' is expected to reach $28.73 million, indicating a decline of 8.8% [8] Stock Performance - Over the past month, shares of Lilly have returned -2.4%, contrasting with the Zacks S&P 500 composite's +0.6% change [8]

Core Viewpoint - Analysts forecast that American International Group (AIG) will report quarterly earnings of $1.58 per share, reflecting a year-over-year increase of 36.2%, with revenues expected to reach $6.82 billion, a 2.7% increase compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been adjusted downward by 2% over the past 30 days, indicating a reassessment by covering analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Key Metrics Estimates - General Insurance - Net premiums earned are expected to be $5.96 billion, a 3.7% increase year-over-year [5]. - General Insurance - Net investment income is projected at $784.38 million, reflecting a 5.2% year-over-year increase [5]. - Other Operations - Net investment income and other is estimated at $88.75 million, indicating a significant decline of 37.1% year-over-year [5]. Revenue and Ratios - Total net investment income is expected to be $946.23 million, showing a decrease of 4.4% year-over-year [6]. - General Insurance - Combined ratio is projected to be 90.4%, improving from 92.5% in the same quarter last year [6]. - General Insurance - Expense ratio is expected to be 30.8%, down from 31.5% in the previous year [7]. - General Insurance - Loss ratio is anticipated to be 59.6%, compared to 61.0% a year ago [7]. Income Forecast - General Insurance - Adjusted pre-tax income is forecasted to reach $1.34 billion, up from $1.18 billion reported in the same quarter last year [8]. Stock Performance - AIG shares have decreased by 6.7% over the past month, contrasting with the S&P 500 composite's increase of 2.3% [8].